Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.

TitleExploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.
Publication TypeJournal Article
Year of Publication2014
AuthorsMarquis, J, Schneider, MP, Spencer, B, Bugnon, O, Pasquier, SDu
JournalInternational Journal of Clinical Pharmacy
Volume36
Issue5
Pagination1014-1022
Date Published10/2014
DOI10.1007/s11096-014-9989-7
ISSN2210-7711
Abstract

BACKGROUND: Medication adherence has been identified as an important factor for clinical success. Twenty-four Swiss community pharmacists participated in the implementation of an adherence support programme for patients with hypertension, diabetes mellitus and/or dyslipidemia. The programme combined tailored consultations with patients about medication taking (expected at an average of one intervention per month) and the delivery of each drug in an electronic monitoring system (MEMS6™).

OBJECTIVE: To explore pharmacists' perceptions and experiences with implementation of the medication adherence programme and to clarify why only seven patients were enrolled in total.

SETTING: Community pharmacies in French-speaking Switzerland.

METHOD: Individual in-depth interviews were audio-recorded, with 20 of the pharmacists who participated in the adherence programme. These were transcribed verbatim, coded and thematically analysed. Process quality was ensured by using an audit trail detailing the development of codes and themes; furthermore, each step in the coding and analysis was verified by a second, experienced qualitative researcher.

MAIN OUTCOME MEASURE: Community pharmacists' experiences and perceptions of the determining factors influencing the implementation of the adherence programme.

RESULTS: Four major barriers were identified: (1) poor communication with patients resulting in insufficient promotion of the programme; (2) insufficient collaboration with physicians; (3) difficulty in integrating the programme into pharmacy organisation; and (4) insufficient pharmacist motivation. This was related to the remuneration perceived as insufficient and to the absence of clear strategic thinking about the pharmacist position in the health care system. One major facilitator of the programme's implementation was pre-existing collaboration with physicians.

CONCLUSION: A wide range of barriers was identified. The implementation of medication adherence programmes in Swiss community pharmacies would benefit from an extended training aimed at developing communication and change management skills. Individualised onsite support addressing relevant barriers would also be necessary throughout the implementation process.

Notes

Publication types: Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish

Alternate URL

http://www.ncbi.nlm.nih.gov/pubmed/25139136?dopt=Abstract

First publication date (online)

08/2014

WOS ID (UT)

000343647000021

Alternate JournalInt J Clin Pharm
Citation Key / SERVAL ID3602
Peer reviewRefereed
PubMed ID25139136
Thème IUMSP et mots clés: 

                         

IUMSP | www.iumsp.ch
Institute of Social and Preventive Medicine
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | dess.info@unisante.ch

Go to top